Innovative Therapeutics CohBar specializes in mitochondria-based therapeutics targeting chronic and age-related diseases, presenting opportunities to introduce advanced biotech solutions and companion diagnostics that enhance their pipeline development and clinical trials.
Strategic Mergers The recent merger with Morphogenesis indicates a focus on expanding late-stage oncology offerings, suggesting a potential need for oncology-focused infrastructure, clinical support services, and innovative drug delivery systems.
Funding and Scale With $15M funding and a revenue range of $1M to $10M, CohBar is positioned for growth, opening avenues to offer scalable research tools, bioprocessing technology, or specialized laboratory services tailored to early-stage biotech companies.
Leadership & Expertise The appointment of experienced directors and medical officers highlights a focus on scientific excellence, creating opportunities for partnership in medical research, advisory services, and clinical development consultancy.
Technology Stack Utilizing cloud-based solutions like AWS and web technologies such as WordPress and Google Fonts, CohBar demonstrates a tech-savvy profile that aligns with opportunities in digital health solutions, biotech informatics, and data management platforms.
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10B
$10BCohBar, Inc. uses 8 technology products and services including Amazon Web Services, Open Graph, RSS, and more. Explore CohBar, Inc.'s tech stack below.
| CohBar, Inc. Email Formats | Percentage |
| First.Last@cohbar.com | 94% |
| Last.First@cohbar.com | 3% |
| Fir.Last@cohbar.com | 3% |
Biotechnology ResearchCalifornia, United States2-10 Employees
CohBar is a clinical-stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to no treatment options.
Company Overview
Funding & FinancialsCohBar, Inc. has raised a total of $15M of funding over 5 rounds. Their latest funding round was raised on Oct 28, 2021 in the amount of $15M.
CohBar, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & FinancialsCohBar, Inc. has raised a total of $15M of funding over 5 rounds. Their latest funding round was raised on Oct 28, 2021 in the amount of $15M.
CohBar, Inc.'s revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com